Scientific, clinical, regulatory, and economic aspects of choosing bone graft/biological options in spine surgery

Kyle A. Smith, Glenn S. Russo, Alexander R. Vaccaro, Paul M. Arnold

Research output: Contribution to journalReview articlepeer-review

Abstract

Spinal arthrodesis is a major element of the spinal surgeon's practice. To attain successful fusion rates, attentionmust be paid to spinal segment immobilization and proper selection of bone graft. Autogenous bone graft (ie, ICBG), the "gold standard," with or without graft extenders and enhancers provides the foundation for most spinal fusions. ABG is the only graft option containing all 3 factors of new bone growth: osteoconductivity, osteoinductivity, and osteogenicity. While many bone graft alternatives function well as bone graft extenders, only growth factors proteins (ie, rhBMP-2 or OP-2) function as bone graft enhancers and substitutes. The search for optimal hybrid interbody cages, bone graft substitutes, autogenous or allogenic stem cells, and nanostructure scaffolds for release of growth factors continues.

Original languageEnglish (US)
Pages (from-to)827-835
Number of pages9
JournalClinical Neurosurgery
Volume84
Issue number4
DOIs
StatePublished - Apr 1 2019
Externally publishedYes

Keywords

  • Allograft
  • Autograft
  • Bone biologics
  • Bone marrowaspirate
  • Bonemorphogenic protein
  • Osteoconductivity
  • Osteogenicity
  • Osteoinductivity
  • Synthetics

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Scientific, clinical, regulatory, and economic aspects of choosing bone graft/biological options in spine surgery'. Together they form a unique fingerprint.

Cite this